Last updated 2026-06-18
Total raised
—
Stage
Mature
Founded
2006
Headcount
31
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
BetaStimhas developed a minimally invasive implantable pulse generator that treats obesity and type II diabetes by applying electrical stimulation to the duodenum.
Q&A
- What is BetaStim's primary focus?
- BetaStim develops implantable pulse generators designed to treat obesity and type II diabetes by applying electrical stimulation to the duodenum.
- Where is BetaStim headquartered?
- BetaStim is headquartered in Caesarea, Center District, Israel.
- When was BetaStim founded?
- BetaStim was founded in January 2006.
- What is BetaStim's current operational status?
- BetaStim is currently inactive, as of November 2016.
- How many employees does BetaStim have?
- BetaStim has an employee count in the 11-50 range.
- What sector does BetaStim primarily operate in?
- BetaStim's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
- What is the product stage of BetaStim's offerings?
- BetaStim's product is currently released.
- Who is listed as the CEO of BetaStim?
- Vardit Segal is listed as the CEO of BetaStim.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
diabetesmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2006-1 |
|---|---|
| Employees (exact) | 31 |
| Status reason | Non Active, Nov 2016 |